Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/08998280.2021.1873032 http://scihub22266oqcxt.onion/10.1080/08998280.2021.1873032 33953457!8059886!33953457     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Proc+(Bayl+Univ+Med+Cent) 2021 ; 34 (3): 345-348 Nephropedia Template TP {{tp|p=33953457|t=2021. Trends in post-heart transplant biopsies for graft rejection versus nonrejection |pdf=|usr=}}{{33953457}} gab.com Text Trends in post-heart transplant biopsies for graft rejection versus nonrejection JO: Proc (Bayl Univ Med Cent) http://www.kidney.de/pget.php?&tw=1&pmid=33953457 #FOAvip With alternatives such as gene profiling available for surveillance after orthotopic heart transplantation, we sought to evaluate the utilization of endomyocardial biopsies (EMBs) for hospitalized patients after heart transplantation. Surveillance EMBs in patients with and without complications were evaluated from the 2004 to 2014 National Inpatient Sample. Over the study period, there was no significant change in the number of EMB procedures performed (P = 0.44). Of 37,955 EMBs, 2283 (6%) were in the setting of graft complications, while 35,672 EMBs were not related to graft complications. EMBs in graft complications did not show a significant increase in length of stay over time (P = 0.06), but had a significant increase in cost over time (P = 0.001). However, those with graft complications had an average of a 5-day longer length of stay (P < 0.001) and costs that were $88,816 (P < 0.001) more expensive compared with those without graft complications. In conclusion, the vast majority of in-hospital EMBs were not related to heart transplantation complications. Nevertheless, EMB hospitalizations with graft complications showed significantly greater length of stay and cost. With the COVID-19 pandemic, it seems more effective to use minimal-contact health surveillance methods rather than invasive EMBs. Twit Text FOAVip Trends in post-heart transplant biopsies for graft rejection versus nonrejection ????Proc (Bayl Univ Med Cent) http://www.kidney.de/pget.php?&tw=1&pmid=33953457 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33953457 #FOAvip English Wikipedia <ref>{{Cite pmid|33953457}}</ref> Trends in post-heart transplant biopsies for graft rejection versus nonrejection #MMPMID33953457 Jamil AK; Afzal A; Nisar T; Kluger AY; Felius J; Wencker D; Hall SA; Kale P Proc (Bayl Univ Med Cent) 2021[Jan]; 34 (3): 345-348 PMID33953457show ga With alternatives such as gene profiling available for surveillance after orthotopic heart transplantation, we sought to evaluate the utilization of endomyocardial biopsies (EMBs) for hospitalized patients after heart transplantation. Surveillance EMBs in patients with and without complications were evaluated from the 2004 to 2014 National Inpatient Sample. Over the study period, there was no significant change in the number of EMB procedures performed (P = 0.44). Of 37,955 EMBs, 2283 (6%) were in the setting of graft complications, while 35,672 EMBs were not related to graft complications. EMBs in graft complications did not show a significant increase in length of stay over time (P = 0.06), but had a significant increase in cost over time (P = 0.001). However, those with graft complications had an average of a 5-day longer length of stay (P < 0.001) and costs that were $88,816 (P < 0.001) more expensive compared with those without graft complications. In conclusion, the vast majority of in-hospital EMBs were not related to heart transplantation complications. Nevertheless, EMB hospitalizations with graft complications showed significantly greater length of stay and cost. With the COVID-19 pandemic, it seems more effective to use minimal-contact health surveillance methods rather than invasive EMBs. äTrends in post-heart transplant biopsies for graft rejection versus no(epmc).pdf DeepDyve Pubget Overpricing